DOI zum Zitieren der Version auf EPub Bayreuth: https://doi.org/10.15495/EPub_UBT_00006656
URN to cite this document: urn:nbn:de:bvb:703-epub-6656-4
URN to cite this document: urn:nbn:de:bvb:703-epub-6656-4
Title data
Englmeier, Fabienne ; Bleckmann, Annalen ; Brückl, Wolfgang ; Griesinger, Frank ; Fleitz, Annette ; Nagels, Klaus:
Clinical benefit and cost‑effectiveness analysis of liquid biopsy
application in patients with advanced non‑small cell lung cancer
(NSCLC) : a modelling approach.
In: Journal of Cancer Research and Clinical Oncology.
(9 May 2022)
.
ISSN 1432-1335
DOI der Verlagsversion: https://doi.org/10.1007/s00432-022-04034-w
|
|||||||||
Download (4MB)
|
Further data
Item Type: | Article in a journal |
---|---|
Keywords: | Liquid biopsy; Cost-effectiveness; NSCLC; Molecular profiling |
DDC Subjects: | 600 Technology, medicine, applied sciences > 610 Medicine and health |
Institutions of the University: | Faculties > Faculty of Law, Business and Economics > Department of Economics > Former Professors > Chair Healthcare Management and Research - Univ.-Prof. Dr. Klaus Nagels Faculties Faculties > Faculty of Law, Business and Economics Faculties > Faculty of Law, Business and Economics > Chair Healthcare Management and Research Faculties > Faculty of Law, Business and Economics > Department of Economics Faculties > Faculty of Law, Business and Economics > Department of Economics > Former Professors |
Language: | English |
Originates at UBT: | Yes |
URN: | urn:nbn:de:bvb:703-epub-6656-4 |
Date Deposited: | 16 Sep 2022 06:09 |
Last Modified: | 16 Sep 2022 06:10 |
URI: | https://epub.uni-bayreuth.de/id/eprint/6656 |